Diabetes Mellitus and Its Effects on All-Cause Mortality After Radiopeptide Therapy for Neuroendocrine Tumors.

Umlauft, Maria; Radojewski, Piotr; Spanjol, Petar-Marko; Dumont, Rebecca; Marincek, Nicolas; Kollar, Attila; Brunner, Philippe; Beyersmann, Jan; Müller-Brand, Jan; Maecke, Helmut R; Laimer, Markus; Walter, Martin A

Umlauft, Maria; Radojewski, Piotr; Spanjol, Petar-Marko; Dumont, Rebecca; Marincek, Nicolas; Kollar, Attila; Brunner, Philippe; Beyersmann, Jan; Müller-Brand, Jan; Maecke, Helmut R; Laimer, Markus; Walter, Martin A.

Afiliação

Umlauft M; Institute of Nuclear Medicine, University Hospital Bern, Bern, Switzerland.
Radojewski P; Institute of Statistics, Ulm University, Ulm, Germany.
Spanjol PM; Institute of Nuclear Medicine, University Hospital Bern, Bern, Switzerland.
Dumont R; Institute of Nuclear Medicine, University Hospital Bern, Bern, Switzerland.
Marincek N; Institute of Nuclear Medicine, University Hospital Bern, Bern, Switzerland.
Kollar A; Institute of Nuclear Medicine, University Hospital Bern, Bern, Switzerland.
Brunner P; Institute of Nuclear Medicine, University Hospital Basel, Basel, Switzerland.
Beyersmann J; Division of Medical Oncology, University Hospital Bern, Bern, Switzerland.
Müller-Brand J; Institute of Nuclear Medicine, University Hospital Basel, Basel, Switzerland.
Maecke HR; Institute of Statistics, Ulm University, Ulm, Germany.
Laimer M; Institute of Nuclear Medicine, University Hospital Basel, Basel, Switzerland.
Walter MA; Department of Nuclear Medicine, University Hospital Freiburg, Freiburg, Germany; and.

J Nucl Med ; 58(1): 97-102, 2017 Jan.

Article em En | MEDLINE | ID: mdl-27635023

Assuntos

Complicações do Diabetes/mortalidade; Tumores Neuroendócrinos/mortalidade; Tumores Neuroendócrinos/radioterapia; Octreotida/análogos & derivados; Compostos Organometálicos/uso terapêutico; Adolescente; Adulto; Idoso; Idoso de 80 Anos ou mais; Criança; Comorbidade; Feminino; Humanos; Masculino; Pessoa de Meia-Idade; Octreotida/uso terapêutico; Prevalência; Compostos Radiofarmacêuticos/uso terapêutico; Fatores de Risco; Taxa de Sobrevida; Suíça/epidemiologia; Resultado do Tratamento; Adulto Jovem

Palavras-chave

adverse event; metabolic therapy; sstr2; targeted therapy; toxicity

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos Organometálicos / Octreotida / Tumores Neuroendócrinos / Complicações do Diabetes Tipo de estudo: Clinical_trials / Etiology_studies / Prevalence_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Child / Female / Humans / Male / Middle aged País como assunto: Europa Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google